Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in miceQinyu Wang,Yangjie Ou,Guomin Hu,Cong Wen,Shanshan Yue,Cong Chen,Lu Xu,Jiawei Xie,Hui Dai,Han Xiao,Youyi Zhang,Rong QiBritish Journal of Pharmacology(2020)引用 91|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要